354 related articles for article (PubMed ID: 20400863)
1. Therapeutic antibodies, vaccines and antibodyomes.
Dimitrov DS
MAbs; 2010; 2(3):347-56. PubMed ID: 20400863
[TBL] [Abstract][Full Text] [Related]
2. Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.
Crowe JE
Cell Host Microbe; 2017 Aug; 22(2):193-206. PubMed ID: 28799905
[TBL] [Abstract][Full Text] [Related]
3. Overview of monoclonal antibodies in the diagnosis and therapy of cancer.
Vaickus L; Foon KA
Cancer Invest; 1991; 9(2):195-209. PubMed ID: 1863875
[TBL] [Abstract][Full Text] [Related]
4. Antibodies. The future is now. Introduction.
Mueller KL
Science; 2013 Sep; 341(6151):1191. PubMed ID: 24031010
[No Abstract] [Full Text] [Related]
5. The development of immunotoxins for the therapy of cancer, AIDS, and immune dysfunctions.
Vitetta ES
Princess Takamatsu Symp; 1988; 19():333-40. PubMed ID: 3077626
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.
Silveira EL; Kasturi SP; Kovalenkov Y; Rasheed AU; Yeiser P; Jinnah ZS; Legere TH; Pulendran B; Villinger F; Wrammert J
J Immunol Methods; 2015 Jan; 416():69-83. PubMed ID: 25445326
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells.
Bodey B
Expert Opin Biol Ther; 2001 Jul; 1(4):603-17. PubMed ID: 11727497
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the acquired immune deficiency syndrome.
Gupta S; Gottlieb MS
J Clin Immunol; 1986 May; 6(3):183-93. PubMed ID: 2424929
[TBL] [Abstract][Full Text] [Related]
9. Recent mechanistic insights on glycoconjugate vaccines and future perspectives.
Berti F; Adamo R
ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibodies for discovery, therapy, and vaccine acceleration.
Andreano E; Seubert A; Rappuoli R
Curr Opin Immunol; 2019 Aug; 59():130-134. PubMed ID: 31450054
[TBL] [Abstract][Full Text] [Related]
11. Preparation and use of therapeutic antibodies primarily of human origin.
Stiehm ER; Keller MA; Vyas GN
Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic antibodies: magic bullets hit the target.
Gura T
Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
[No Abstract] [Full Text] [Related]
13. The expanding role of therapeutic antibodies.
Salemi S; Markovic M; Martini G; D'Amelio R
Int Rev Immunol; 2015 May; 34(3):202-64. PubMed ID: 24471447
[TBL] [Abstract][Full Text] [Related]
14. Role of monoclonal antibodies in tumor-specific immunity.
Nicodemus CF; Smith LM; Schultes BC
Expert Opin Biol Ther; 2007 Mar; 7(3):331-43. PubMed ID: 17309325
[TBL] [Abstract][Full Text] [Related]
15. [Monoclonal anti-HIV antibodies in HIV/AIDS research. Diagnosis and therapy].
Giese R; Grunow R
Allerg Immunol (Leipz); 1989; 35(1):25-37. PubMed ID: 2718887
[TBL] [Abstract][Full Text] [Related]
16. Which are the antibodies to watch in 2012?
Reichert JM
MAbs; 2012; 4(1):1-3. PubMed ID: 22327425
[No Abstract] [Full Text] [Related]
17. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
18. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.
Lohmueller J; Finn OJ
Pharmacol Ther; 2017 Oct; 178():31-47. PubMed ID: 28322974
[TBL] [Abstract][Full Text] [Related]
19. Are mimotope vaccines a good alternative to monoclonal antibodies?
Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
